ATE154388T1 - Verwendung von modifiziertem heparin kofaktor ii - Google Patents

Verwendung von modifiziertem heparin kofaktor ii

Info

Publication number
ATE154388T1
ATE154388T1 AT90870188T AT90870188T ATE154388T1 AT E154388 T1 ATE154388 T1 AT E154388T1 AT 90870188 T AT90870188 T AT 90870188T AT 90870188 T AT90870188 T AT 90870188T AT E154388 T1 ATE154388 T1 AT E154388T1
Authority
AT
Austria
Prior art keywords
heparin cofactor
modified heparin
hcii
modified
cofactor
Prior art date
Application number
AT90870188T
Other languages
English (en)
Inventor
Douglas Meyer Tollefsen
Vivianna Maia Derechin
Morey Alan Blinder
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of ATE154388T1 publication Critical patent/ATE154388T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT90870188T 1989-10-20 1990-10-15 Verwendung von modifiziertem heparin kofaktor ii ATE154388T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/424,440 US5102995A (en) 1989-10-20 1989-10-20 Dna encoding modified heparin cofactor ii

Publications (1)

Publication Number Publication Date
ATE154388T1 true ATE154388T1 (de) 1997-06-15

Family

ID=23682642

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90870188T ATE154388T1 (de) 1989-10-20 1990-10-15 Verwendung von modifiziertem heparin kofaktor ii

Country Status (9)

Country Link
US (1) US5102995A (de)
EP (1) EP0424351B1 (de)
JP (1) JPH03139280A (de)
AT (1) ATE154388T1 (de)
CA (1) CA2028082A1 (de)
DE (1) DE69030909T2 (de)
DK (1) DK0424351T3 (de)
ES (1) ES2104598T3 (de)
GR (1) GR3024588T3 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291662B1 (en) 1984-12-05 2001-09-18 Amgen Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences
US5871956A (en) * 1984-12-06 1999-02-16 Amgen Inc. Recombinant methods for production of serine inhibitors and DNA sequences useful for same
US5900400A (en) * 1984-12-06 1999-05-04 Amgen Inc. Serine protease inhibitor analogs
US6132990A (en) * 1984-12-06 2000-10-17 Amgen Boulder Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences useful for same
GB9024685D0 (en) * 1990-11-13 1991-01-02 Raleigh Industries Ltd Cycle seat pillar mounting
JP3479539B2 (ja) * 1992-04-10 2003-12-15 エーザイ株式会社 ヒトアンチトロンビンiii変異体
US6303691B1 (en) 1992-07-31 2001-10-16 Exxon Mobil Chemical Patents Inc. Impact modification of polyamides
US6869925B1 (en) * 1992-09-09 2005-03-22 Amgen Inc. Inhibition of retrovirus infection
US6017880A (en) * 1994-03-09 2000-01-25 Amgen Inc. Inhibition of retrovirus infection
JPH09176040A (ja) * 1995-12-27 1997-07-08 Green Cross Corp:The ヘパリンコファクターiiの医薬用途
AU2878199A (en) * 1998-02-27 1999-09-15 University Of North Carolina At Chapel Hill, The Mutant heparin cofactor ii
AU2746399A (en) * 1998-03-09 1999-09-27 Welfide Corporation Heparin cofactor ii-containing compositions and method for stabilizing the same
GB0916578D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
GB2500184A (en) * 2012-03-12 2013-09-18 Ximmune Ab Polypeptide derived from helix A of heparin cofactor II
US20180078916A1 (en) * 2015-03-18 2018-03-22 Carnegie Mellon University Lignin-based surfactants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3521226A1 (de) * 1985-02-08 1986-08-14 Hoechst Ag, 6230 Frankfurt Gene fuer biologisch aktive proteine
US4861865A (en) * 1989-01-23 1989-08-29 Washington University Novel antithrombin peptide

Also Published As

Publication number Publication date
EP0424351B1 (de) 1997-06-11
EP0424351A2 (de) 1991-04-24
CA2028082A1 (en) 1991-04-21
ES2104598T3 (es) 1997-10-16
DK0424351T3 (da) 1997-10-13
GR3024588T3 (en) 1997-12-31
EP0424351A3 (en) 1991-10-09
DE69030909T2 (de) 1998-01-29
JPH03139280A (ja) 1991-06-13
US5102995A (en) 1992-04-07
DE69030909D1 (de) 1997-07-17

Similar Documents

Publication Publication Date Title
DE69030909D1 (de) Verwendung von modifiziertem Heparin Kofaktor II
HUT77431A (hu) Fonálféregből kivont szerinproteáz-inhibitorok és véralvadásgátló proteinek
DE3751742D1 (de) 4,5,6-Substituierte 2-Pyrimidinamine
FI903331A0 (fi) Substituerade kinazolinoner, vilka aer anvaendbara som angiotensin-ii-antagonister.
SE9301270D0 (sv) Biosensor
FI92695B (fi) Uusi menetelmä heksa-, okta- tai dekahydronaftyylietyylisubstituoitujen 4-hydroksitetrahydropyran-2-onijohdannaisten valmistamiseksi
AU3264489A (en) 2-substituted-4-substituted-1,3-dioxalanes, synthesis and use thereof
ES2070116T3 (es) Peptidos que inhiben la union del factor von willebrand.
ES2056851T3 (es) Preparacion de terfenadina polimorficamente pura.
ATE112558T1 (de) Glycosidasehemmer.
ATE90508T1 (de) Verwendung von di-styryl-phenyl-triglykolether als kristallisationsinhibitor.
DE3764724D1 (de) 2-phenylbenzoxepin-derivat.
ATE55039T1 (de) Verwendung von aryloxy-verbindungen als antidots.
DK270789A (da) Hirudin-derivater, deres fremstilling og anvendelse
ATE288922T1 (de) Bestimmte heteroaryl substituierte thiol inhibitoren von endothelin wechselnden enzymen
UA26435A (uk) Каталізатор полімеризації альфа-олефіhів, спосіб одержаhhя поліолефіhів з його використаhhям
DE3787112D1 (de) Menschliche Pankreaselastase I.
DE69200861D1 (de) Konzentration von tert.-Butyl-Hydroperoxid.
DE69023265D1 (de) Holzbearbeitungsklebstoffe auf der Basis von Mehrstufen-Emulsionspolymeren.
DE69006833D1 (de) Verwendung von Stabilisatoren für agrochemische Zusammensetzungen.
ES2060392T3 (es) Nueva region promotora.
DE68924616D1 (de) Verwendung von monomerem Pentabrombenzylmonoacrylat als Flammschutzmittel.
ATE238791T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure als mukolytikum
MX9204642A (es) 1,4-dihidropiridinas con actividad paf-antagonista
ES2106199T3 (es) Derivado de nitroxialquilamida.